Study of GEC255 in Subjects With Advanced Solid Tumors With KRAS p.G12C Mutation
Clinical trial NCT05768321 · UNKNOWN
Trial details
- NCT number
- NCT05768321
- Sponsor
- GenEros Biopharma Hangzhou Ltd
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-11-04
- Primary completion
- 2024-02-28
- Enrollment
- 70
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.